Literature DB >> 11678875

Early-onset hidradenitis suppurativa.

R A Palmer1, M Keefe.   

Abstract

A 9-year-old girl developed hidradenitis suppurativa 3 months after the first signs of adrenarche. Such a close temporal relationship is consistent with the hypothesis that the disease is androgen dependent. Less than 2% of patients have onset of the disease before the age of 11 years. The exceptionally early age of onset in our patient may be partly explained by the fact that she had an early puberty.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11678875     DOI: 10.1046/j.1365-2230.2001.00876.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  8 in total

Review 1.  Hidradenitis suppurativa in children and adolescents: a review of treatment options.

Authors:  Peter Riis Mikkelsen; Gregor B E Jemec
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

Review 2.  Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?

Authors:  Ioannis Karagiannidis; Georgios Nikolakis; Robert Sabat; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 3.  Finasteride in Hidradenitis Suppurativa: A "Male" Therapy for a Predominantly "Female" Disease.

Authors:  Birgit N Khandalavala; Melissa Voutsalath Do
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

Review 4.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

5.  Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.

Authors:  Errol P Prens; Aida M Lugo-Somolinos; Amy S Paller; Francisco Kerdel; Yinghui Duan; Henrique D Teixeira; Michelle Longcore; Alexa B Kimball
Journal:  Am J Clin Dermatol       Date:  2020-08       Impact factor: 7.403

6.  Disseminate Recurrent Folliculitis and Hidradenitis Suppurativa Are Associated Conditions: Results From a Retrospective Study of 131 Patients With Down Syndrome and a Cohort of 12,351 Pediatric Controls.

Authors:  Andrea Sechi; Alba Guglielmo; Annalisa Patrizi; Francesco Savoia; Guido Cocchi; Miriam Leuzzi; Marco A Chessa
Journal:  Dermatol Pract Concept       Date:  2019-07-31

Review 7.  Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.

Authors:  Wayne Gulliver; Christos C Zouboulis; Errol Prens; Gregor B E Jemec; Thrasivoulos Tzellos
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 8.  Hidradenitis suppurativa: infection, autoimmunity, or both?

Authors:  Costas A Constantinou; George E Fragoulis; Elena Nikiphorou
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-12-30       Impact factor: 5.346

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.